Dr. Kaufman was a panelist for the Forum’s discussion on Gene Editing.
Howard Kaufman is Professor of Surgery at the Robert Wood Johnson Medical School at Rutgers, The State University of New Jersey. He is also a Surgical Oncologist at the Rutgers Cancer Institute of New Jersey and member of the Recombinant DNA Advisory Committee at the U.S. National Institutes of Health.
Dr. Kaufman was recruited to the Rutgers Cancer Institute of New Jersey in 2014 to join an established team of doctors and scientists who have dedicated themselves to finding new treatments and providing the highest quality of care for patients with melanoma and related skin cancers.
Dr. Kaufman did my residency at Boston University and completed two fellowship programs in Surgical Oncology and Tumor Immunology, both at the National Cancer Institute. Following his training he moved to New York City where he established the Columbia University Melanoma Center and established an NIH-funded laboratory in tumor immunology. His clinical practice included patients from both the New York and New Jersey area. In 2009 he moved to Rush University in Chicago to help build a new Cancer Center and established the Rush Melanoma Center where he continued my research into understanding how the immune system can be used to treat melanoma and Merkel cell carcinoma. In 2014Dr. Kaufman was able to return to the New Jersey area and bring his clinical and laboratory experience to the well-known NCI-designated comprehensive cancer center at Rutgers.
Dr. Kaufman’s professional career has provided him with many honors and he has published over 200 scientific papers, books, book chapters and abstracts. In addition to scientific papers, he authored The Melanoma Book as a resource for patients and family members dealing with the diagnosis of melanoma.Dr. Kaufman has served on the Board of the Melanoma Research Foundation, Society of Melanoma Research and the American Cancer Society Eastern Division.Dr. Kaufman has also been a member of the Commission on Cancer and was elected President of the Society for Immunotherapy of Cancer in 2014. He is also a member of several other professional societies, including the American College of Surgeons, Society for Surgical Oncology and Society of University Surgeons.Dr. Kaufman has served on several national review committees for the National Cancer Institute and National Institutes of Health and has been on several editorial boards for medical journals and currently serves as the Editor-in-Chief for the Journal of Immunotherapy Applications.
